61272
document
A randomized , double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms .
61273
Intervention_Pharmacological
atomoxetine
61274
Intervention_Control
placebo
61275
Participant_Age
children
61276
Participant_Age
adolescents
61277
Participant_Condition
autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms